[Can angiotensin-converting enzyme inhibitor be used in chronic kidney disease patients with serum creatinine level greater than 266 micromol/L?].

Author: HouFan-fan, LiuQiong-fang, ZhangGuo-hua, ZhangXun

Paper Details 
Original Abstract of the Article :
Angiotensin-converting enzyme inhibitor (ACEI) has been demonstrated to have protective effect for patients with mild to moderate chronic kidney disease (CKD). However, little evidence is available for the benefit or side-effects of ACEI in treating patients with more severe CKD. A prospective, rand...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/16194413

データ提供:米国国立医学図書館(NLM)

ACE Inhibitors: Exploring Their Potential in Severe CKD

In the management of chronic kidney disease (CKD), the use of angiotensin-converting enzyme inhibitors (ACEIs) has proven beneficial for patients with mild to moderate disease. However, their effectiveness and safety in treating more severe CKD remain unclear. This study investigated the potential renal protective effects and safety of ACEIs in patients with serum creatinine levels greater than 265 micromol/L. Researchers conducted a prospective, randomized controlled trial to evaluate the impact of ACEIs on this patient population. The study aimed to shed light on the role of ACEIs in managing severe CKD.

ACEIs: A Potential Tool for Severe CKD Management

This study offers valuable insights into the potential benefits and risks of ACEIs in managing patients with severe CKD. The study highlights the need for further research to fully understand the role of ACEIs in this complex patient population. The findings provide a foundation for future investigations and clinical practice guidelines for managing severe CKD.

Navigating CKD: A Multidisciplinary Approach

This research underscores the importance of a multidisciplinary approach to managing CKD. The study highlights the need for careful patient selection and ongoing monitoring to optimize treatment outcomes and minimize potential risks. It's essential to consult with a nephrologist to develop a personalized treatment plan for CKD, considering the individual patient's needs and disease severity.

Dr. Camel's Conclusion

My dear friends, the desert of CKD can be a challenging and unpredictable terrain. This study guides us towards a better understanding of the potential benefits and risks of ACEIs in managing severe CKD. Remember, just as a camel adapts to the harsh desert environment, we can adapt our approach to CKD management to suit individual patient needs. By working together with healthcare professionals, we can find the right path towards healthier outcomes and a more fulfilling life despite the challenges of CKD.
Date :
  1. Date Completed 2006-08-21
  2. Date Revised 2014-02-26
Further Info :

Pubmed ID

16194413

DOI: Digital Object Identifier

16194413

Related Literature

SNS
PICO Info
in preparation
Languages

Chinese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.